Literature DB >> 23948931

Tau oligomers and fibrils induce activation of microglial cells.

Inelia Morales1, José M Jiménez, Marcela Mancilla, Ricardo B Maccioni.   

Abstract

Neuroinflammation is a process related to the onset of several neurodegenerative disorders, including Alzheimer's disease (AD). Increasing sets of evidence support the major role of deregulation of the interaction patterns between glial cells and neurons in the pathway toward neuronal degeneration, a process we are calling neuroimmunomodulation in AD. On the basis of the hypothesis that pathological tau aggregates induce microglial activation with the subsequent events of the neuroinflammatory cascade, we have studied the effects of tau oligomeric species and filamentous structures over microglial cells in vitro. Tau oligomers and fibrils were induced by arachidonic acid and then their actions assayed upon addition to microglial cells. We showed activation of the microglia, with significant morphological alterations as analyzed by immunofluorescence. The augmentation of nitrites and the proinflammatory cytokine IL-6 was evaluated in ELISA assays. Furthermore, conditioned media of stimulated microglia cells were exposed to hippocampal neurons generating altered patterns in these cells, including shortening of neuritic processes and cytoskeleton reorganization.

Entities:  

Keywords:  Alzheimer's disease; glial cells; neuroinflammation; tau aggregates

Mesh:

Substances:

Year:  2013        PMID: 23948931     DOI: 10.3233/JAD-131843

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  47 in total

Review 1.  Microglial priming in Alzheimer's disease.

Authors:  Jun-Wei Li; Yu Zong; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

2.  Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease.

Authors:  William C Kreisl; Chul Hyoung Lyoo; Jeih-San Liow; Joseph Snow; Emily Page; Kimberly J Jenko; Cheryl L Morse; Sami S Zoghbi; Victor W Pike; R Scott Turner; Robert B Innis
Journal:  Neurobiol Aging       Date:  2016-12-16       Impact factor: 4.673

Review 3.  Neuroinflammatory responses in Alzheimer's disease.

Authors:  Cira Dansokho; Michael Thomas Heneka
Journal:  J Neural Transm (Vienna)       Date:  2017-12-22       Impact factor: 3.575

Review 4.  Neuroinflammation in Neurodegenerative Disorders-a Review.

Authors:  Martin Schain; William Charles Kreisl
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

Review 5.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.

Authors:  Yu Tang; Weidong Le
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

6.  Synthesis and biological evaluation of substituted N-[3-(1H-pyrrol-1-yl)methyl]-1,2,5,6-tetrahydropyridin-1-yl]benzamide/benzene sulfonamides as anti-inflammatory agents.

Authors:  Madhavi Gangapuram; Elizabeth Mazzio; Suresh Eyunni; Karam F A Soliman; Kinfe K Redda
Journal:  Arch Pharm (Weinheim)       Date:  2014-03-02       Impact factor: 3.751

7.  Distinct Neurotoxic Effects of Extracellular Tau Species in Primary Neuronal-Glial Cultures.

Authors:  Katryna Pampuscenko; Ramune Morkuniene; Lukas Krasauskas; Vytautas Smirnovas; Taisuke Tomita; Vilmante Borutaite
Journal:  Mol Neurobiol       Date:  2020-10-01       Impact factor: 5.590

8.  Increased tauopathy drives microglia-mediated clearance of beta-amyloid.

Authors:  Wesley Chen; Edsel A Abud; Stephen T Yeung; Anita Lakatos; Trevor Nassi; Jane Wang; David Blum; Luc Buée; Wayne W Poon; Mathew Blurton-Jones
Journal:  Acta Neuropathol Commun       Date:  2016-06-23       Impact factor: 7.801

9.  Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.

Authors:  Thuy-Vi V Nguyen; Lin Shen; Lilith Vander Griend; Lisa N Quach; Nadia P Belichenko; Nay Saw; Tao Yang; Mehrdad Shamloo; Tony Wyss-Coray; Stephen M Massa; Frank M Longo
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 10.  The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target.

Authors:  Jin Chu; Domenico Praticò
Journal:  Brain Res Bull       Date:  2016-03-19       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.